https://www.onhealthcare.tech/p/how-the-trump-administration-andThoughts on Healthcare Markets & Technologyen2026-06-07T14:12:39+00:00How the Trump Administration and a Cohort of AI Startups Are Building a Regulatory On-Ramp for Autonomous AI Doctors, and Why Working Physicians Think the Genie Is Already Out of the Bottlehttps://www.onhealthcare.tech/p/part-ii-how-the-trump-administrationThoughts on Healthcare Markets & Technologyen2026-06-07T14:01:35+00:00Part II: How the Trump Administration and a Cohort of AI Startups Are Building a Regulatory On-Ramp for Autonomous AI Doctors, and Why Working Physicians Think the Genie Is Already Out of the Bottlehttps://www.onhealthcare.tech/p/part-i-how-the-trump-administrationThoughts on Healthcare Markets & Technologyen2026-06-07T13:20:09+00:00Part I: How the Trump Administration and a Cohort of AI Startups Are Building a Regulatory On-Ramp for Autonomous AI Doctors, and Why Working Physicians Think the Genie Is Already Out of the Bottlehttps://www.onhealthcare.tech/p/how-fdas-june-2026-draft-guidance-cb6Thoughts on Healthcare Markets & Technologyen2026-06-06T10:59:10+00:00How FDA’s June 2026 Draft Guidance Lets Genome Editing Sponsors Reuse CMC, Nonclinical, Bioinformatics, and Clinical Data Across Programs, and Where the Agency Still Wants Product Specific Work Done https://www.onhealthcare.tech/p/how-fdas-june-2026-draft-guidanceThoughts on Healthcare Markets & Technologyen2026-06-06T10:52:24+00:00How FDA’s June 2026 Draft Guidance Lets Genome Editing Sponsors Reuse CMC, Nonclinical, Bioinformatics, and Clinical Data Across Programs, and Where the Agency Still Wants Product Specific Work Done